Gene · 719
Papers2,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mitochondrial C3aR and endoplasmic reticulum C5aR orchestrate calcium imbalance during oxidative stress in retinal pigment epithelial cells. | Mitochondrion | 2026 | 42242609 | PubTator, text mining | PubMed |
| Complement C3a Receptor 1 and Complement C5a Receptor 1 Are Dual Contributors of Chronic-Plus-Binge-Induced Hepatic Inflammation and Injury. | Am J Pathol | 2026 | 42217620 | PubTator, text mining | PubMed |
| Aryl hydrocarbon receptor alleviates intestinal ischemia/reperfusion-induced epithelial barrier damage by inhibiting the 5-hydroxytryptamine-mediated complement C3 cascade. | Int J Biol Macromol | 2026 | 42214532 | PubTator, text mining | PubMed |
| Anti-PLA2R antibodies promote endothelial pyroptosis and a procoagulant phenotype through FcγRI signaling. | Nephrol Dial Transplant | 2026 | 42127088 | PubTator, text mining | PubMed |
| Identification of potential biological targets in sepsis based on random forest and artificial neural network models. | J Infect Dev Ctries | 2026 | 42112730 | PubTator, text mining | PubMed |
| Shared immune-inflammatory gene networks and drug prediction in polycystic ovary syndrome and type 2 diabetes mellitus: a bioinformatics and experimental validation study. | Front Endocrinol (Lausanne) | 2026 | 42109727 | PubTator, text mining | PubMed |
| Complement Dysregulation During the Early Phases of Synucleinopathy. | bioRxiv | 2026 | 42094452 | PubTator, text mining | PubMed |
| Targeting the C3 signaling axis of the complement system: immune microenvironment regulation and emerging therapeutic strategies for glioblastoma. | Front Immunol | 2026 | 42039201 | PubTator, text mining | PubMed |
| Macrophage C3aR1 Mediates Sepsis-Induced Myocardial Injury by Triggering Neutrophil Necroptosis. | J Cell Mol Med | 2026 | 42002824 | PubTator, text mining | PubMed |
| The Role of the C3a-C3aR Pathway in Diseases: Latest Research Advances. | Mediators Inflamm | 2026 | 41999083 | PubTator, text mining | PubMed |
| Bindarit attenuates brain injury and neuroinflammation in status epilepticus by disrupting C3/C3aR signaling and modulating microglia-astrocyte interactions. | Cell Commun Signal | 2026 | 41975466 | PubTator, text mining | PubMed |
| Exoproteome of calorie-restricted humans identifies complement deactivation as an immunometabolic checkpoint reducing inflammaging. | Nat Aging | 2026 | 41974968 | PubTator, text mining | PubMed |
| Metabolic and inflammatory roles of glial cells in neurodegenerative and cerebrovascular diseases. | Ageing Res Rev | 2026 | 41932503 | PubTator, text mining | PubMed |
| Comparison of Complement Receptor Markers C5aR (CD88) and C3aR on Lymphocyte and Monocyte Subpopulations in Peripheral Blood of Serum IgE Positive and Negative Asthmatic Adults. | Ann Clin Lab Sci | 2026 | 41927112 | PubTator, text mining | PubMed |
| Immunological Basis of Chronic Spontaneous Urticaria: Immunoglobulin E and Beyond. | Yonsei Med J | 2026 | 41914312 | PubTator, text mining | PubMed |
| Astrocytes in neuroinflammation and brain cancer. | Mol Biomed | 2026 | 41910655 | PubTator, text mining | PubMed |
| New Frontiers in the Pathophysiology of Hypertensive Pregnancy Disorders: A Systematic Review of Molecular Insights into Preeclampsia. | Curr Issues Mol Biol | 2026 | 41899446 | PubTator, text mining | PubMed |
| Adventitial Niches, Complement and Inflammation in Pulmonary Vascular Disease: Current Status and Future Directions. | Compr Physiol | 2026 | 41889113 | PubTator, text mining | PubMed |
| Deciphering the toxicological mechanism of airway allergic diseases caused by dioctyl terephthalate: a composite study. | Front Toxicol | 2026 | 41884324 | PubTator, text mining | PubMed |
| Therapeutic strategy for cervical gastric-type adenocarcinoma by targeting CLU to relieve CLU-associated stress and sensitize chemotherapy. | Precis Clin Med | 2026 | 41878236 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/719/papers?page=2